Abstract PA-2: Cost Consequences of Initiating Palonosetron versus Other 5-Hydroxytryptamine 3 Receptor Antagonists for Prevention of Chemotherapy-Induced Nausea and Vomiting among Patients with Cancer Treated with Highly Emetogenic Chemotherapy in a Hospital Outpatient Setting

✍ Scribed by Sanjeev Balu; Chris Craver; Julie Gayle; Deborah Buchner

• Book ID: 116893202
• Publisher: Frontline Medical Communications, Inc.
• Year: 2010
• Tongue: English
• Weight: 125 KB
• Volume: 8
• Category: Article
• ISSN: 1544-6794
• DOI: 10.1016/j.suponc.2010.09.008